Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Myk-461
1. Camzyos
2. 1642288-47-8
3. Mavacamten [inn]
4. Mavacamten [usan]
5. Mavacamten [who-dd]
6. Myk-461
7. 6-[[(1s)-1-phenylethyl]amino]-3-propan-2-yl-1h-pyrimidine-2,4-dione
8. Qx45b99r3j
9. Sar-439152
10. (s)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1h,3h)-dione
11. Sar439152
12. 2,4(1h,3h)-pyrimidinedione, 3-(1-methylethyl)-6-(((1s)-1-phenylethyl)amino)-
13. 2,4(1h,3h)-pyrimidinedione, 3-(1-methylethyl)-6-[[(1s)-1-phenylethyl]amino]-
14. Mavacamten (myk-461)
15. Unii-qx45b99r3j
16. Myk461
17. Chembl4297517
18. Schembl16320785
19. Gtpl11265
20. Ex-a2072
21. Bdbm50575174
22. S8861
23. Who 10492
24. Db14921
25. Myk-461; Mavacamten; Sar439152
26. Sar-439152; Myk-461
27. Hy-109037
28. Cs-0031211
29. E83742
30. (s)-3-isopropyl-6-((1-phenylethyl)amino) Pyrimidine-2,4(1h,3h)-dione
31. (s)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2, 4(1h,3h)-dione
32. (s)-3-isopropyl-6-(1-phenylethylamino)pyrimidine-2,4(1h,3h)-dione
33. 3-(1-methylethyl)-6-[[(1s)-1-phenylethyl]amino]-2,4(1h,3h)-pyrimidinedione
34. 6-(((1s)-1-phenylethyl)amino)-3-(propan-2-yl)-1,2,3,4 Tetrahydropyrimidine-2,4-dione
35. 6-{[(1s)-1-phenylethyl]amino}-3-(propan-2-yl)pyrimidine-2,4(1h,3h)-dione
Molecular Weight | 273.33 g/mol |
---|---|
Molecular Formula | C15H19N3O2 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 273.147726857 g/mol |
Monoisotopic Mass | 273.147726857 g/mol |
Topological Polar Surface Area | 61.4 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 411 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of hypertrophic cardiomyopathy
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38462
Submission : 2023-06-22
Status : Active
Type : II
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39772
Submission : 2024-03-29
Status : Active
Type : II
Available Reg Filing : BR |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38462
Submission : 2023-06-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39772
Submission : 2024-03-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2025-05-06
Pay. Date : 2025-04-04
DMF Number : 41326
Submission : 2025-03-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41499
Submission : 2025-03-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41418
Submission : 2025-05-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41362
Submission : 2025-03-18
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41081
Submission : 2024-12-31
Status : Active
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 69988-0060
Start Marketing Date : 2022-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 81666-008
Start Marketing Date : 2025-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-050
Start Marketing Date : 2024-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50193-4423
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48957-0091
Start Marketing Date : 2022-04-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates, CDMO/CRO/OEM, and Technology Transfer of Finished Formulat...
About the Company : HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-g...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Maithri Drugs Pvt. Ltd. is a trusted global partner in Active Pharmaceutical Ingredients (APIs), supplying to pharmaceutical leaders in 60+ countries. With APIs spanning antivirals...
RLD : Yes
TE Code :
Brand Name : CAMZYOS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2.5MG
Approval Date : 2022-04-28
Application Number : 214998
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : CAMZYOS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 5MG
Approval Date : 2022-04-28
Application Number : 214998
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : CAMZYOS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Approval Date : 2022-04-28
Application Number : 214998
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : CAMZYOS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 15MG
Approval Date : 2022-04-28
Application Number : 214998
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Camzyos
Dosage Form : Capsule
Dosage Strength : 10mg
Packaging :
Approval Date : 26/06/2023
Application Number : 20210628000045
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Camzyos
Dosage Form : Capsule
Dosage Strength : 15mg
Packaging :
Approval Date : 26/06/2023
Application Number : 20210628000052
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Camzyos
Dosage Form : Capsule
Dosage Strength : 2.5mg
Packaging :
Approval Date : 26/06/2023
Application Number : 20210628000021
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Camzyos
Dosage Form : Capsule
Dosage Strength : 5mg
Packaging :
Approval Date : 26/06/2023
Application Number : 20210628000038
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Camzyos
Dosage Form : Hard Capsule
Dosage Strength : 15MG
Packaging :
Approval Date : 2023-07-03
Application Number : 1231716008
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Camzyos
Dosage Form : Hard Capsule
Dosage Strength : 5MG
Packaging :
Approval Date : 2023-07-03
Application Number : 1231716004
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Camzyos
Dosage Form : Hard Capsule
Dosage Strength : 10MG
Packaging :
Approval Date : 2023-07-03
Application Number : 1231716006
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Camzyos
Dosage Form : Hard Capsule
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2023-07-03
Application Number : 1231716002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CAMZYOS
Dosage Form : CAPSULE
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number : 2532549
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CAMZYOS
Dosage Form : CAPSULE
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 2532557
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CAMZYOS
Dosage Form : CAPSULE
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2532565
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CAMZYOS
Dosage Form : CAPSULE
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 2532573
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Camzyos
Dosage Form :
Dosage Strength :
Packaging : 28
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Global Sales Information
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 24
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 231
2022 Revenue in Millions : 24
Growth (%) : 863
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2024 Revenue in Millions : 602
2023 Revenue in Millions : 231
Growth (%) : 161
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of Mavacamten API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mavacamten manufacturer or Mavacamten supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mavacamten manufacturer or Mavacamten supplier.
PharmaCompass also assists you with knowing the Mavacamten API Price utilized in the formulation of products. Mavacamten API Price is not always fixed or binding as the Mavacamten Price is obtained through a variety of data sources. The Mavacamten Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mavacamten manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mavacamten, including repackagers and relabelers. The FDA regulates Mavacamten manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mavacamten API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mavacamten manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mavacamten supplier is an individual or a company that provides Mavacamten active pharmaceutical ingredient (API) or Mavacamten finished formulations upon request. The Mavacamten suppliers may include Mavacamten API manufacturers, exporters, distributors and traders.
click here to find a list of Mavacamten suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mavacamten DMF (Drug Master File) is a document detailing the whole manufacturing process of Mavacamten active pharmaceutical ingredient (API) in detail. Different forms of Mavacamten DMFs exist exist since differing nations have different regulations, such as Mavacamten USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mavacamten DMF submitted to regulatory agencies in the US is known as a USDMF. Mavacamten USDMF includes data on Mavacamten's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mavacamten USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mavacamten suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mavacamten as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mavacamten API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mavacamten as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mavacamten and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mavacamten NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mavacamten suppliers with NDC on PharmaCompass.
Mavacamten Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mavacamten GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mavacamten GMP manufacturer or Mavacamten GMP API supplier for your needs.
A Mavacamten CoA (Certificate of Analysis) is a formal document that attests to Mavacamten's compliance with Mavacamten specifications and serves as a tool for batch-level quality control.
Mavacamten CoA mostly includes findings from lab analyses of a specific batch. For each Mavacamten CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mavacamten may be tested according to a variety of international standards, such as European Pharmacopoeia (Mavacamten EP), Mavacamten JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mavacamten USP).